Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:21:57 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



Q:TPST - TEMPEST THERAPEUTICS INC - http://www.tempestasset.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TPST - Q0.53.43·3.565.03.47-0.15-4.1298.49691,0143.52  3.55  3.449.77  0.1717:51:07Apr 2615 min RT 2¢

Recent Trades - Last 10 of 1014
Time ETExPriceChangeVolume
17:51:07Q3.4422-0.1778500
17:40:50Q3.4457-0.1743192
17:32:44Q3.48-0.1415
16:40:01Q3.46-0.168
16:09:57Q3.54-0.081
16:08:48Q3.54-0.0810
16:03:22Q3.54-0.081
16:00:01Q3.47-0.154
16:00:01Q3.47-0.1584
16:00:01Q3.47-0.1533

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-26 16:05U:TPSTNews ReleaseTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-04-09 08:00U:TPSTNews ReleaseTempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
2024-04-04 08:00U:TPSTNews ReleaseTempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
2024-03-19 16:26U:TPSTNews ReleaseTempest Reports Year End 2023 Financial Results and Provides Business Update
2024-03-12 08:00U:TPSTNews ReleaseTempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
2024-03-05 16:30U:TPSTNews ReleaseTempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
2024-02-26 08:00U:TPSTNews ReleaseTempest to Present at the 44th Annual TD Cowen Healthcare Conference
2024-02-02 16:30U:TPSTNews ReleaseTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-01-05 16:05U:TPSTNews ReleaseTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-12-01 16:16U:TPSTNews ReleaseTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-11-20 08:00U:TPSTNews ReleaseTempest to Present at the 35th Annual Piper Sandler Healthcare Conference
2023-11-08 17:18U:TPSTNews ReleaseTempest Reports Third Quarter 2023 Financial Results and Provides Business Update
2023-10-11 08:01U:TPSTNews ReleaseTempest Adopts Limited Duration Stockholder Rights Plan
2023-10-11 08:00U:TPSTNews ReleaseTempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study
2023-10-10 16:05U:TPSTNews ReleaseTempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
2023-09-19 08:00U:TPSTNews ReleaseTempest Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and Development
2023-09-05 08:00U:TPSTNews ReleaseTempest to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-10 16:14U:TPSTNews ReleaseTempest Reports Second Quarter 2023 Financial Results and Provides Business Update
2023-07-19 08:00U:TPSTNews ReleaseTempest Announces Publication in Cancer Research Communications Highlighting TPST-1495 Significantly Increased Potency Against Prostaglandin-Driven Tumor Models by Blocking EP2 and EP4 Together
2023-05-31 16:05U:TPSTNews ReleaseTempest to Present at the Jefferies Global Healthcare Conference